A urinary biomarker-based risk score correlates with multiparametric MRI for prostate cancer detection.

about

Advances in Biomarkers for PCa Diagnostics and Prognostics-A Way towards Personalized Medicine.A panel of DNA methylation markers for the detection of prostate cancer from FV and DRE urine DNA.

P2860

Q47096463-657E289D-645D-4920-9918-83A2449F0BDA Q55517990-04E9367B-4D1C-4947-AEF1-6F6C1C4A614A

P2860

A urinary biomarker-based risk score correlates with multiparametric MRI for prostate cancer detection.

Item

http://www.wikidata.org/entity/Q38602540

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

A urinary biomarker-based risk ...... for prostate cancer detection.

@en

type

Item

label

A urinary biomarker-based risk ...... for prostate cancer detection.

@en

prefLabel

A urinary biomarker-based risk ...... for prostate cancer detection.

@en

P1476

A urinary biomarker-based risk ...... for prostate cancer detection

@en

P2093

Christina A Hulsbergen-van de Kaa

http://www.w3.org/2001/XMLSchema#string

Jack A Schalken

http://www.w3.org/2001/XMLSchema#string

Jelle O Barentsz

http://www.w3.org/2001/XMLSchema#string

Marloes M G van der Leest

http://www.w3.org/2001/XMLSchema#string

Peter F A Mulders

http://www.w3.org/2001/XMLSchema#string

Rianne J Hendriks

http://www.w3.org/2001/XMLSchema#string

Siebren Dijkstra

http://www.w3.org/2001/XMLSchema#string

Wim Van Criekinge

http://www.w3.org/2001/XMLSchema#string

P2860

ESUR prostate MR guidelines 2012

Overdiagnosis and overtreatment of prostate cancer

PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2

New targets for therapy in prostate cancer: differential display code 3 (DD3(PCA3)), a highly prostate cancer-specific gene.

Prognostic Gleason grade grouping: data based on the modified Gleason scoring system.

The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.

Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: The role of systematic and targeted biopsies.

EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013.

Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature.

Predictive value of negative 3T multiparametric magnetic resonance imaging of the prostate on 12-core biopsy results.

P304

1401-1407

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PROS.23401

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Inge M. Van Oort

P577

2017-08-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28853167

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

A urinary biomarker-based risk score correlates with multiparametric MRI for prostate cancer detection.

about

P2860

P2860

A urinary biomarker-based risk score correlates with multiparametric MRI for prostate cancer detection.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921